ici 118551 and Cholangiocarcinoma

ici 118551 has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham, G; Günl, B; Hauss, J; Kassahun, WT; Tannapfel, A; Ungemach, FR	1

Trials

1 trial(s) available for ici 118551 and Cholangiocarcinoma

Article	Year
Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C. Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 372, Issue:3 Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; CA-19-9 Antigen; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Propanolamines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Type C Phospholipases	2005

Article

Year

Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C.

Naunyn-Schmiedeberg's archives of pharmacology, 2005, Volume: 372, Issue:3

Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; CA-19-9 Antigen; Cholangiocarcinoma; Female; Humans; Liver Neoplasms; Male; Propanolamines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-2; Type C Phospholipases

2005